TGF-β signaling from receptors to smads

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 9, 2016, Pages

  Hata, Akiko ^a   Chen, Ye Guang ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; HUMAN; METABOLISM; PROTEIN PROCESSING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84986210662     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a022061     Document Type: Article

References (302)

1. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2–Smad4 complex formation and signaling. J Biol Chem 272: 27678–27685.
2. Agricola E, Randall RA, Gaarenstroom T, Dupont S, Hill CS. 2011. Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell 43: 85–96.
3. Ahmed MI, Mardaryev AN, Lewis CJ, Sharov AA, Botchkareva NV. 2011. MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes. J Cell Sci 124: 3399–3404.
4. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al. 2009. Nuclear CDKs drive Smad transcriptional acti- vation and turnover in BMP and TGF-β pathways. Cell 139: 757–769.
5. Al-Salihi MA, Herhaus L, Macartney T, Sapkota GP. 2012. USP11 augments TGFβ signalling by deubiquitylating ALK5. Open Biol 2: 120063.
6. Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. 2011. A Smad action turnover switch operated by WW domain readers of a phospho-serine code. Genes Dev 25: 1275–1288.
7. Atfi A, Dumont E, Colland F, Bonnier D, L’Helgoualc’h A, Prunier C, Ferrand N, Clement B, Wewer UM, Theret N. 2007. The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor. J Cell Biol 178: 201–208.
8. Bai Y, Yang W, Yang HX, Liao Q, Ye G, Fu G, Ji L, Xu P, Wang H, Li YX, et al. 2012. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS ONE 7: e38875.
9. Bakkebo M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP. 2012. SARA is dispensable for functional TGF-β signaling. FEBS Lett 586: 3367–3372.
10. Balderman JA, Lee HY, Mahoney CE, Handy DE, White K, Annis S, Lebeche D, Hajjar RJ, Loscalzo J, Leopold JA. 2012. Bone morphogenetic protein-2 decreases micro-RNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc 1: e003905.
11. Bao Y, Chen Z, Guo Y, Feng Y, Li Z, Han W, Wang J, Zhao W, Jiao Y, Li K, et al. 2014. Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. PLoS ONE 9: e105991.
12. Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D, et al. 2006. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 20: 3130–3146.
13. Batut J, Howell M, Hill CS. 2007. Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-β ligands. Dev Cell 12: 261–274.
14. Bengtsson L, Schwappacher R, Roth M, Boergermann JH, Hassel S, Knaus P. 2009. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. J Cell Sci 122: 1248–1257.
15. Bennett D, Alphey L. 2002. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster. Nat Genet 31: 419–423.
16. Berenguer J, Herrera A, Vuolo L, Torroba B, Llorens F, Sumoy L, Pons S. 2013. MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors. Mol Cell Biol 33: 2706–2717.
17. Blahna MT, Hata A. 2012. Smad-mediated regulation of microRNA biosynthesis. FEBS Lett 586: 1906–1912.
18. Blahna MT, Hata A. 2013. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr Opin Cell Biol 25: 233–240.
19. Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ, Hoeben RC, Akhyari P, Al-Ha-sani H, Ruige JB, et al. 2013. Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143. Cardiovasc Res 100: 201–210.
20. Bruce DL, Macartney T, Yong W, Shou W, Sapkota GP. 2012. Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-β pathway. Cell Signal 24: 1999–2006.
21. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9: 582–589.
22. Cao H, Jheon A, Li X, Sun Z, Wang J, Florez S, Zhang Z, McManus MT, Klein OD, Amendt BA. 2013. The Pitx2: miR-200c/141:noggin pathway regulates Bmp signaling and ameloblast differentiation. Development 140: 3348– 3359.
23. Cárcamo J, Zentella A, Massagué J. 1995. Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 15: 1573–1581.
24. Chen RH, Derynck R. 1994. Homomeric interactions between type II transforming growth factor-β receptors. J Biol Chem 269: 22868–22874.
25. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. 1995. AWD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377: 548–552.
26. Chen YG, Liu F, Massagué J. 1997. Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J 16: 3866–3876.
27. Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J. 1998. Determinants of specificity in TGF-β signal transduction. Genes Dev 12: 2144–2152.
28. Chen HB, Rud JG, Lin K, Xu L. 2005. Nuclear targeting of transforming growth factor-β-activated Smad complexes. J Biol Chem 280: 21329–21336.
29. Chen HB, Shen J, Ip YT, Xu L. 2006. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev 20: 648–653.
30. Chen YG, Wang Z, Ma J, Zhang L, Lu Z. 2007. Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-β signaling. J Biol Chem 282: 9688–9695.
31. Chen F, Lin X, Xu P, Zhang Z, Chen Y, Wang C, Han J, Zhao B, Xiao M, Feng XH. 2015. Nuclear export of Smads by RanBP3L regulates bone morphogenetic protein signaling and mesenchymal stem cell differentiation. Mol Cell Biol 35: 1700–1711.
32. Cheung KS, Sposito N, Stumpf PS, Wilson DI, SanchezElsner T, Oreffo RO. 2014. MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PLoS ONE 9: e98063.
33. Choi SJ, Moon JH, Ahn YW, Ahn JH, Kim DU, Han TH. 2005. Tsc-22 enhances TGF-β signaling by associating with Smad4 and induces erythroid cell differentiation. Mol Cell Biochem 271: 23–28.
34. Choy L, Derynck R. 1998. The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response. J Biol Chem 273: 31455–31462.
35. Colas AR, McKeithan WL, Cunningham TJ, Bushway PJ, Garmire LX, Duester G, Subramaniam S, Mercola M. 2012. Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis. Genes Dev 26: 2567–2579.
36. Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. 2004. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol 6: 366–372.
37. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. 2009. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4: e5279.
38. Dai F, Lin X, Chang C, Feng XH. 2009. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-β signaling. Dev Cell 16: 345–357.
39. Datta PK, Moses HL. 2000. STRAP and Smad7 synergize in the inhibition of transforming growth factorβ signaling. Mol Cell Biol 20: 3157–3167.
40. Datta PK, Chytil A, Gorska AE, Moses HL. 1998. Identification of STRAP, a novel WD domain protein in transforming growth factor-β signaling. J Biol Chem 273: 34671–34674.
41. Davis BN, Hilyard AC, Lagna G, Hata A. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56–61.
42. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373–384.
43. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A. 2011. Down-regulation of Krüppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-β and bone morphogenetic protein 4. J Biol Chem 286: 28097– 28110.
44. Deheuninck J, Luo K. 2009. Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res 19: 47–57.
45. De Strooper B, Iwatsubo T, Wolfe MS. 2012. Presenilins and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med 2: a006304.
46. Du J, Yang S, An D, Hu F, Yuan W, Zhai C, Zhu T. 2009. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing δEF1 and AP-1. Cell Res 19: 487–496.
47. Duan X, Liang YY, Feng XH, Lin X. 2006. Protein serine/ threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 281: 36526–36532.
48. Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S, Fischer JC, Wang Y, Cleaver O, Qyang Y, Ober EA, et al. 2014. Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ Res 114: 56–66.
49. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. 2005. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121: 87–99.
50. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, et al. 2009. FAM/USP9x, a deubiquitinating enzyme essential for TGF-β signaling, controls Smad4 monoubiquitination. Cell 136: 123–135.
51. Durrington HJ, Upton PD, Hoer S, Boname J, Dunmore BJ, Yang J, Crilley TK, Butler LM, Blackbourn DJ, Nash GB, et al. 2010. Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem 285: 37641–37649.
52. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477–12480.
53. Feng XH, Derynck R. 1997. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J 16: 3912–3923.
54. Feng XH, Derynck R. 2005. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21: 659–693.
55. Ferrand N, Atfi A, Prunier C. 2010. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-β type I receptor. Cancer Res 70: 8457–8466.
56. Flotho A, Melchior F. 2013. Sumoylation: A regulatory protein modification in health and disease. Annu Rev Biochem 82: 357–385.
57. Fu G, Ye G, Nadeem L, Ji L, Manchanda T, Wang Y, Zhao Y, Qiao J, Wang YL, Lye S, et al. 2013. MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension 61: 864–872.
58. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/ Smad1 signal. Cell 131: 980–993.
59. Fukasawa H, Yamamoto T, Fujigaki Y, Misaki T, Ohashi N, Takayama T, Suzuki S, Mugiya S, Oda T, Uchida C, et al. 2010. Reduction of transforming growth factor-β type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. Int J Cancer 127: 1517–1525.
60. Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, Miyazono K. 2001. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell 12: 1431–1443.
61. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, et al. 2007. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Bio 9: 604–611.
62. Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. 2001. Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway. Mol Cell Biol 21: 5132–5141.
63. Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massagué J. 2009. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell 36: 457–468.
64. Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. 2011. Stage-specific modulation of cortical neuronal development by Mμ-miR-134. Cereb Cortex 21: 1857–1869.
65. Gilboa L, Wells RG, Lodish HF, Henis YI. 1998. Oligomeric structure of type I and type II transforming growth factor β receptors: Homodimers form in the ER and persist at the plasma membrane. J Cell Biol 140: 767–777.
66. Goh JB, Wallace DF, Hong W, Subramaniam VN. 2015. Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin. Sci Rep 5: 13986.
67. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593–601.
68. Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. 1998. Physical and functional interactions between type I transforming growth factor β receptors and Ba, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 18: 6595–6604.
69. Grönroos E, Hellman U, Heldin CH, Ericsson J. 2002. Control of Smad7 stability by competition between acetyla-tion and ubiquitination. Mol Cell 10: 483–493.
70. Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuermann JP, Taylor AB, Schwarz PM, Wrana JL, Hinck AP. 2008. Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell 29: 157–168.
71. Gudey SK, Sundar R, Mu Y, Wallenius A, Zang G, Bergh A, Heldin CH, Landstrom M. 2014. TRAF6 stimulates the tumor-promoting effects of TGF-β type I receptor through polyubiquitination and activation of presenilin 1. Sci Signal 7: ra2.
72. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. 2008. Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling. Genes Dev 22: 106–120.
73. Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, et al. 2014. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. Carcinogenesis 35: 1698–1706.
74. Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15: 509–524.
75. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. 2006. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26: 7791–7805.
76. Hata A, Lieberman J. 2015. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal 8: re3.
77. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, et al. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89: 1165–1173.
78. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. 2006. Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGF-β pathway. Cell 125: 929–941.
79. Henis YI, Moustakas A, Lin HY, Lodish HF. 1994. The types II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol 126: 139–154.
80. Hill CS. 2009. Nucleocytoplasmic shuttling of Smad proteins. Cell Res 19: 36–46.
81. Hocevar BA, Smine A, Xu XX, Howe PH. 2001. The adaptor molecule disabled-2 links the transforming growth factor β receptors to the Smad pathway. EMBO J 20: 2789– 2801.
82. Hu F, Meng X, Tong Q, Liang L, Xiang R, Zhu T, Yang S. 2013. BMP-6 inhibits cell proliferation by targeting mi-croRNA-192 in breast cancer. Biochim Biophys Acta 1832: 2379–2390.
83. Huang F, Chen YG. 2012. Regulation of TGF-β receptor activity. Cell Biosci 2: 9.
84. Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, et al. 2008. Upregulation of miR-23aα 27aα24 decreases transforming growth factor-β-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972–978.
85. Huang T, David L, Mendoza V, Yang Y, Villarreal M, De K, Sun L, Fang X, Lopez-Casillas F, Wrana JL, et al. 2011. TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs. EMBO J 30: 1263–1276.
86. Huse M, Chen YG, Massagué J, Kuriyan J. 1999. Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12. Cell 96: 425–436.
87. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J. 2001. The TGFβ receptor activation process: An inhibitorto substrate-binding switch. Mol Cell 8: 671–682.
88. Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, Kim CS, Suh N. 2014. miR-140–5p suppresses BMP2mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 588: 2957–2963.
89. Imamura T, Oshima Y, Hikita A. 2013. Regulation of TGF-β family signalling by ubiquitination and deubiquitination. J Biochem 154: 481–489.
90. Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A, Onozaki K, Hayashi H. 2007. Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene 26: 500–508.
91. Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, Enzo E, Moro S, Polo S, Dupont S, et al. 2011. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol 13: 1368–1375.
92. Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke Pt P. 2002. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells 7: 321–331.
93. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. 2003. Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J Biol Chem 278: 3751–3761.
94. Itoh T, Nozawa Y, Akao Y. 2009. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distalless homeobox 5. J Biol Chem 284: 19272–19279.
95. Jin Q, Gao G, Mulder KM. 2009. Requirement of a dynein light chain in TGF-β/Smad3 signaling. J Cell Physiol 221: 707–715.
96. Kang Y, Chen CR, Massagué J. 2003. A self-enabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11: 915–926.
97. Kang JS, Saunier EF, Akhurst RJ, Derynck R. 2008. The type I TGF-β receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 10: 654–664.
98. Kang JS, Liu C, Derynck R. 2009. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol 19: 385–394.
99. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell 6: 1365–1375.
100. Kawamata H, Fujimori T, Imai Y. 2004. TSC-22 (TGF-β stimulated clone-22): A novel molecular target for differentiation-inducing therapy in salivary gland cancer. Curr Cancer Drug Targets 4: 521–529.
101. Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, Clermont FF, Wu G, Roy R, Letteboer TG, et al. 2014. Genetic variants of Adam17 differentially regulate TGF-β signaling to modify vascular pathology in mice and humans. Proc Natl Acad Sci 111: 7723–7728.
102. Kim YJ, Hwang SJ, Bae YC, Jung JS. 2009. MiR-21 regulates adipogenic differentiation through the modulation of TGF-β signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27: 3093–3102.
103. Kim SJ, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, Chun KH. 2011. Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 155: 427–434.
104. Kim S, Hata A, Kang H. 2014. Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation. J Cell Biochem 115: 889–895.
105. Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K. 2004. Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene 23: 6914–6923.
106. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910–14914.
107. Kowanetz M, Lönn P, Vanlandewijck M, Kowanetz K, Heldin CH, Moustakas A. 2008. TGF-β induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol 182: 655–662.
108. Kretzschmar M, Doody J, Massagué J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389: 618–622.
109. Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T. 2005. NEDD 4–2 (neural precursor cell expressed, developmentally down-regulated 4–2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J 386: 461–470.
110. Kurisaki A, Kose S, Yoneda Y, Heldin CH, Moustakas A. 2001. Transforming growth factor-β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner. Mol Biol Cell 12: 1079–1091.
111. Kurisaki A, Kurisaki K, Kowanetz M, Sugino H, Yoneda Y, Heldin CH, Moustakas A. 2006. The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. Mol Cell Biol 26: 1318–1332.
112. Labbé E, Letamendia A, Attisano L. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci 97: 8358–8363.
113. Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L. 2007. Transcriptional cooperation between the transforming growth factor-β and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 67: 75–84.
114. Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. 1997. The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 272: 14850–14859.
115. Lee PS, Chang C, Liu D, Derynck R. 2003. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-β family signaling. J Biol Chem 278: 27853–27863.
116. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957–3967.
117. Le Scolan E, Zhu Q, Wang L, Bandyopadhyay A, Javelaud D, Mauviel A, Sun L, Luo K. 2008. Transforming growth factor-β suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res 68: 3277–3285.
118. Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. 2007. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27: 6068–6083.
119. Li L, Xin H, Xu X, Huang M, Zhang X, Chen Y, Zhang S, Fu XY, Chang Z. 2004. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol 24: 856–864.
120. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. 2008. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci 105: 13906–13911.
121. Li L, Shi JY, Zhu GQ, Shi B. 2012. MiR-17–92 cluster regulates cell proliferation and collagen synthesis by targeting TGFβ pathway in mouse palatal mesenchymal cells. J Cell Biochem 113: 1235–1244.
122. Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, Li T, Li X, Liu Y, Huangfu L, et al. 2014. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther 22: 1122–1133.
123. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769–773.
124. Lin HY, Wang XF. 1992. Expression cloning of TGF-β receptors. Mol Reprod Dev 32: 105–110.
125. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. 1992. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785.
126. Lin X, Liang M, Feng XH. 2000. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J Biol Chem 275: 36818–36822.
127. Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F, Feng XH. 2003. Activation of transforming growth factor-β signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem 278: 18714–18719.
128. Lin HK, Bergmann S, Pandolfi PP. 2004. Cytoplasmic PML function in TGF-β signalling. Nature 431: 205–211.
129. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, et al. 2006. PPM1A functions as a Smad phosphatase to terminate TGF-β signaling. Cell 125: 915–928.
130. Lin EA, Kong L, Bai XH, Luan Y, Liu CJ. 2009. miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284: 11326–11335.
131. Lin HS, Gong JN, Su R, Chen MT, Song L, Shen C, Wang F, Ma YN, Zhao HL, Yu J, et al. 2014. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/ EBPα expression. J Leukoc Biol 96: 1023–1035.
132. Lindsay ME, Holaska JM, Welch K, Paschal BM, Macara IG. 2001. Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export. J Cell Biol 153: 1391–1402.
133. Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T, Sander C, Studer L, Betel D. 2011. Genomewide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev 25: 2173–2186.
134. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. 1997. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci 94: 10669–10674.
135. Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, et al. 2006. Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO J 25: 1646–1658.
136. Liu C, Xu P, Lamouille S, Xu J, Derynck R. 2009. TACE-mediated ectodomain shedding of the type I TGF-β receptor downregulates TGF-β signaling. Mol Cell 35: 26– 36.
137. Liu X, Ma Y, Zhang C, Wei S, Cao Y, Wang Q. 2013. Nodal promotes mir206 expression to control convergence and extension movements during zebrafish gastrulation. J Genet Genomics 40: 515–521.
138. Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J. 1998. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J 17: 996–1005.
139. Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. 2012. Overexpression of miR-370 and downregulation of its novel target TGF-β-RII contribute to the progression of gastric carcinoma. Oncogene 31: 226–237.
140. Long J, Wang G, He D, Liu F. 2004. Repression of Smad4 transcriptional activity by SUMO modification. Biochem J 379: 23–29.
141. Long J, Badal SS, Wang Y, Chang BH, Rodriguez A, Danesh FR. 2013. MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney. J Biol Chem 288: 36202–36214.
142. Lönn P, Morén A, Raja E, Dahl M, Moustakas A. 2009. Regulating the stability of TGF-β receptors and Smads. Cell Res 19: 21–35.
143. Lönn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. 2010. PARP-1 attenuates Smad-mediated transcription. Mol Cell 40: 521–532.
144. Lu Y, Jiang F, Zheng X, Katakowski M, Buller B, To SS, Chopp M. 2011. TGF-β1 promotes motility and inva-siveness of glioma cells through activation of ADAM17. Oncol Rep 25: 1329–1335.
145. Luo K, Lodish HF. 1997. Positive and negative regulation of type II TGF-β receptor signal transduction by autophos-phorylation on multiple serine residues. EMBO J 16: 1970–1981.
146. Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, Dunk C, Lye S, Peng C. 2012. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci 125: 3124–3132.
147. Luo T, Cui S, Bian C, Yu X. 2014. Crosstalk between TGF-β/ Smad3 and BMP/BMPR2 signaling pathways via miR-17–92 cluster in carotid artery restenosis. Mol Cell Biochem 389: 169–176.
148. Lv S, Sun B, Dai C, Shi R, Zhou X, Lv W, Zhong X, Wang R, Ma W. 2014. The downregulation of microRNA-146a modulates TGF-β signaling pathways activity in glioblastoma. Mol Neurobiol 52: 1257–1262
149. Malapeira J, Esselens C, Bech-Serra JJ, Canals F, Arribas J. 2011. ADAM17 (TACE) regulates TGF-β signaling through the cleavage of vasorin. Oncogene 30: 1912–1922.
150. Martello G, Zacchigna L, Inui M, Montagner M, Adorno M, Mamidi A, Morsut L, Soligo S, Tran U, Dupont S, et al. 2007. MicroRNA control of Nodal signalling. Nature 449: 183–188.
151. Massagué J. 1998. TGF-β signal transduction. Annu Rev Biochem 67: 753–791.
152. Massagué J. 2012. TGF-β signalling in context. Nat Rev Mol Cell Biol 13: 616–630.
153. Massagué J, Chen YG. 2000. Controlling TGF-β signaling. Genes Dev 14: 627–644.
154. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430: 226–231.
155. Matsuura I, Chiang KN, Lai CY, He DM, Wang GN, Ramkumar R, Uchida T, Ryo A, Lu KP, Liu F. 2010. Pin1 promotes transforming growth factor-β-induced migration and invasion. J Biol Chem 285: 1754–1764.
156. McGonigle S, Beall MJ, Feeney EL, Pearce EJ. 2001. Conserved role for 14–3-3ε downstream of type I TGF-β receptors. FEBS Lett 490: 65–69.
157. McGonigle S, Beall MJ, Pearce EJ. 2002. Eukaryotic initiation factor 2α subunit associates with TGF-β receptors and 14-3-3ε and acts as a modulator of the TGF-β response. Biochemistry 41: 579–587.
158. Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, Zhang YE. 2009. A negative feedback control of transforming growth factor-β signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem 284: 19808–19816.
159. Miura S, Takeshita T, Asao H, Kimura Y, Murata K, Sasaki Y, Hanai JI, Beppu H, Tsukazaki T, Wrana JL, et al. 2000. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol 20: 9346–9355.
160. Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kane-saki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, et al. 2009. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 583: 2263–2268.
161. Morén A, Imamura T, Miyazono K, Heldin CH, Moustakas A. 2005. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 280: 22115–22123.
162. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, Gregory RI. 2014. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156: 893–906.
163. Moustakas A, Heldin CH. 2009. The regulation of TGF-β signal transduction. Development 136: 3699–3714.
164. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymo-vych M, Hermansson A, Dimitriou H, Bengoechea-Alonso MT, Ericsson J, et al. 2011. TRAF6 ubiquitinates TGF-β type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330.
165. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14: 2809–2817.
166. Murakami K, Mathew R, Huang J, Farahani R, Peng H, Olson SC, Etlinger JD. 2010. Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension. Exp Biol Med 235: 805–813.
167. Muthusamy BP, Budi EH, Katsuno Y, Lee MK, Smith SM, Mirza AM, Akhurst RJ, Derynck R. 2015. ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-β-induced Smad activation. PLoS Biol 13: e1002325.
168. Nagalingam RS, Sundaresan NR, Noor M, Gupta MP, Solaro RJ, Gupta M. 2014. Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β1 (TGF-β1)-dependent paracrine mechanism. J Biol Chem 289: 27199–27214.
169. Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, et al. 2007. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling. J Biol Chem 282: 20492–20501.
170. Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, Hirao A. 2010. TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463: 676–680.
171. Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Hanai J, Akiyama H, Abe M, Miyazono K, et al. 2009. Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J Biol Chem 284: 6109–6115.
172. Nakano N, Itoh S, Watanabe Y, Maeyama K, Itoh F, Kato M. 2010. Requirement of TCF7L2 for TGF-β-dependent transcriptional activation of the TMEPAI gene. J Biol Chem 285: 38023–38033.
173. Nakano N, Maeyama K, Sakata N, Itoh F, Akatsu R, Nakata M, Katsu Y, Ikeno S, Togawa Y, Vo Nguyen TT, et al. 2014. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. J Biol Chem 289: 12680–12692.
174. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al. 1997. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389: 631–635.
175. Neel JC, Lebrun JJ. 2013. Activin and TGF-β regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal 25: 1556–1566.
176. Ning G, Liu X, Dai M, Meng A, Wang Q. 2013. MicroRNA-92a upholds Bmp signaling by targeting noggin3 during pharyngeal cartilage formation. Dev Cell 24: 283–295.
177. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. 2005. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci 118: 643–650.
178. Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F, Wrana JL. 2005. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell 19: 297–308.
179. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C. 1999. Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401: 480– 485.
180. Oved S, Mosesson Y, Zwang Y, Santonico E, Shtiegman K, Marmor MD, Kochupurakkal BS, Katz M, Lavi S, Cesareni G, et al. 2006. Conjugation to Nedd8 instigates ubiq-uitylation and down-regulation of activated receptor tyrosine kinases. J Biol Chem 281: 21640–21651.
181. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. Regulation of the polarity protein Par6 by TGF-β receptors controls epithelial cell plasticity. Science 307: 1603–1609.
182. Penheiter SG, Singh RD, Repellin CE, Wilkes MC, Edens M, Howe PH, Pagano RE, Leof EB. 2010. Type II transforming growth factor-β receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell 21: 4009–4019.
183. Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engstrom U, Heldin CH, Funa K, ten Dijke P. 1998. The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation. FEBS Lett 434: 83–87.
184. 1 arrest. Genes Dev 14: 3093–3101.
185. Pierreux CE, Nicolas FJ, Hill CS. 2000. Transforming growth factor β-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 20: 9041–9054.
186. Rabut G, Peter M. 2008. Function and regulation of protein neddylation. “Protein modifications: Beyond the usual suspects” review series. EMBO Rep 9: 969–976.
187. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. 2010. Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis. Proc Natl Acad Sci 107: 3111–3116.
188. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. 2001. Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor. J Biol Chem 276: 6727–6738.
189. Redshaw N, Camps C, Sharma V, Motallebipour M, Guzman-Ayala M, Oikonomopoulos S, Thymiakou E, Ragoussis J, Episkopou V. 2013. TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos. PLoS ONE 8: e55186.
190. Reguly T, Wrana JL. 2003. In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol 13: 216– 220.
191. Remy I, Montmarquette A, Michnick SW. 2004. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6: 358–365.
192. Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R, Rogler LE. 2009. MicroRNA-23b cluster micro-RNAs regulate transforming growth factor-β/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50: 575–584.
193. Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. 2010. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7: 64–77.
194. Sapkota G, Knockaert M, Alarcon C, Montalvo E, Brivanlou AH, Massagué J. 2006. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem 281: 40412–40419.
195. Sato MM, Nashimoto M, Katagiri T, Yawaka Y, Tamura M. 2009. Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun 383: 125–129.
196. Schink KO, Raiborg C, Stenmark H. 2013. Phosphatidyli-nositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling. BioEssays 35: 900–912.
197. Schmierer B, Tournier AL, Bates PA, Hill CS. 2008. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci 105: 6608–6613.
198. Seet LF, Hong W. 2001. Endofin, an endosomal FYVE domain protein. J Biol Chem 276: 42445–42454.
199. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. 2007. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 13: 1324–1332.
200. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S, et al. 2004a. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-β signaling, as a target of the β-catenin pathway in colorectal tumor cells. J Biol Chem 279: 6840–6846.
201. Sekiya T, Oda T, Matsuura K, Akiyama T. 2004b. Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling. Biochem Biophys Res Commun 320: 680–684.
202. Senanayake U, Das S, Vesely P, Alzoughbi W, Frohlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B. 2012. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 33: 1014–1021.
203. Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211–223.
204. Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C. 2011. ERBIN is a new SARA-interacting protein: Competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. J Cell Sci 124: 3209–3222.
205. Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M. 2014. Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β. Mol Biol Cell 25: 1620–1628.
206. Shathasivam P, Kollara A, Ringuette MJ, Virtanen C, Wrana JL, Brown TJ. 2015. Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-β receptor I to inhibit TGF-β signaling. Proc Natl Acad Sci 112: 3000–3009.
207. Shen ZJ, Braun RK, Hu J, Xie Q, Chu H, Love RB, Stodola LA, Rosenthal LA, Szakaly RJ, Sorkness RL, et al. 2012. Pin1 protein regulates Smad protein signaling and pulmonary fibrosis. J Biol Chem 287: 23294–23305.
208. Shen T, Sun C, Zhang Z, Xu N, Duan X, Feng XH, Lin X. 2014. Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. Cell Res 24: 724–741.
209. Shi Y, Massagué J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685–700.
210. Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. 2004. GADD34-PP1c recruited by Smad7 dephosphorylates TGF-β type I receptor. J Cell Biol 164: 291–300.
211. Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. 2007. Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci 120: 1216–1224.
212. Shimada K, Suzuki N, Ono Y, Tanaka K, Maeno M, Ito K. 2008. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone 42: 886–893.
213. Siomi H, Siomi MC. 2010. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323–332.
214. Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, Li M, Deng Z, Qian J, Peng C, et al. 2012. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloprotein-ase-11. Oncotarget 3: 1370–1385.
215. Song H, Wang Q, Wen J, Liu S, Gao X, Cheng J, Zhang D. 2012. ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Int J Mol Sci 13: 2063–2077.
216. Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin CH. 1996. Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J 15: 6231–6240.
217. Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, ten Dijke P, Heldin CH. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 272: 28107–28115.
218. Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, et al. 2013. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest 123: 3600–3613.
219. Stein GS, Lian JB, Stein JL, van Wijnen AJ, Choi JY, Pratap J, Zaidi SK. 2003. Temporal and spatial parameters of skeletal gene expression: Targeting RUNX factors and their coregulatory proteins to subnuclear domains. Connect Tissue Res 44: 149–153.
220. Stroschein SL, Bonni S, Wrana JL, Luo K. 2001. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 15: 2822–2836.
221. Su Y, Zhang L, Gao X, Meng F, Wen J, Zhou H, Meng A, Chen YG. 2007. The evolutionally conserved activity of Dapper2 in antagonizing TGF-β signaling. FASEB J 21: 682– 690.
222. Sun F, Wang J, Pan Q, Yu Y, Zhang Y, Wan Y, Wang J, Li X, Hong A. 2009. Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun 380: 660–665.
223. Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L, Liu Y, Zhu X, Zhan M, Yang Y, et al. 2011. Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J Pathol 225: 364–377.
224. Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T, Miyazono K. 2002. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J Biol Chem 277: 39919–39925.
225. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. Modulation of microRNA processing by p53. Nature 460: 529–533.
226. Swingler TE, Wheeler G, Carmont V, Elliott HR, Barter MJ, Abu-Elmagd M, Donell ST, Boot-Handford RP, Hajihosseini MK, Munsterberg A, et al. 2012. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 64: 1909–1919.
227. Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C, Deng CX, Cheng SY, Zhang YE. 2011. Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J 30: 4777–4789.
228. ten Dijke P, Heldin CH. 2006. The Smad family. In Smad Signal Transduction, Vol. 5 (ed. ten Dijke P, Heldin CH), pp. 1–13. Springer, Dordrecht, The Netherlands.
229. Thien CB, Langdon WY. 2001. Cbl: Many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2: 294–307.
230. Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mym-ryk JS, Tini M, Torchia J. 2012. TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 46: 636–649.
231. Tiago DM, Marques CL, Roberto VP, Cancela ML, Laize V. 2014. Mir-20a regulates in vitro mineralization and BMP signaling pathway by targeting BMP-2 transcript in fish. Arch Biochem Biophys 543: 23–30.
232. Tsai ZY, Singh S, Yu SL, Kao LP, Chen BZ, Ho BC, Yang PC, Li SS. 2010. Identification of microRNAs regulated by activin A in human embryonic stem cells. J Cell Biochem 109: 93–102.
233. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell 95: 779–791.
234. Tu F, Pan ZX, Yao Y, Liu HL, Liu SR, Xie Z, Li QF. 2014. miR-34a targets the inhibin βB gene, promoting granulosa cell apoptosis in the porcine ovary. Genet Mol Res 13: 2504– 2512.
235. Ueberham U, Rohn S, Ueberham E, Wodischeck S, Hilbrich I, Holzer M, Bruckner MK, Gruschka H, Arendt T. 2014. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer’s disease. Neuropathol Appl Neurobiol 40: 815–832.
236. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10: 837–848.
237. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, et al. 2009. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition. Nat Cell Biol 11: 943–950.
238. Wan M, Tang Y, Tytler EM, Lu C, Jin B, Vickers SM, Yang L, Shi X, Cao X. 2004. Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1. J Biol Chem 279: 14484–14487.
239. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lech-leider RJ, Martin J, Manganaro T, Donahoe PK. 1996. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86: 435–444.
240. Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD, Chen YG. 2008. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111: 588–595.
241. Wang G, Matsuura I, He D, Liu F. 2009. Transforming growth factor-β-inducible phosphorylation of Smad3. J Biol Chem 284: 9663–9673.
242. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. 2010a. TGF-β-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29: 1787–1797.
243. Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H, Liu Y, Ma C, Huang L, Zhang L, et al. 2010b. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-β type II receptor. Brain Res 1357: 166–174.
244. Wang Y, Li W, Zang X, Chen N, Liu T, Tsonis PA, Huang Y. 2013. MicroRNA-204-5p regulates epithelial-to-mesen-chymal transition during human posterior capsule opacification by targeting SMAD4. Invest Ophthalmol Vis Sci 54: 323–332.
245. Watanabe M, Masuyama N, Fukuda M, Nishida E. 2000. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep 1: 176–182.
246. Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu M, Itoh F, Satoh K, Wiercinska E, Yang W, Shi L, et al. 2010. TME-PAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol Cell 37: 123–134.
247. Watson IR, Irwin MS, Ohh M. 2011. NEDD8 pathways in cancer, Sine Quibus Non. Cancer Cell 19: 168–176.
248. Weiss A, Attisano L. 2013. The TGF-β superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol 2: 47–63.
249. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A. 2005. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene 24: 8080–8084.
250. Wieser R, Wrana JL, Massagué J. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14: 2199–2208.
251. Willis SA, Zimmerman CM, Li LI, Mathews LS. 1996. Formation and activation by phosphorylation of activin receptor complexes. Mol Endocrinol 10: 367–379.
252. Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J. 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014.
253. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341–347.
254. Wrighton KH, Lin X, Feng XH. 2008. Critical regulation of TGF-β signaling by Hsp90. Proc Natl Acad Sci 105: 9244–9249.
255. Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, Massagué J, Shi Y. 2000. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287: 92–97.
256. Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H. 2012. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 287: 7503–7511.
257. Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V, et al. 2011. A poised chromatin platform for TGF-β access to master regulators. Cell 147: 1511–1524.
258. Xiao Z, Liu X, Lodish HF. 2000. Importin β mediates nuclear translocation of Smad 3. J Biol Chem 275: 23425– 23428.
259. Xiao Z, Watson N, Rodriguez C, Lodish HF. 2001. Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem 276: 39404–39410.
260. Xiao Z, Brownawell AM, Macara IG, Lodish HF. 2003a. A novel nuclear export signal in Smad1 is essential for its signaling activity. J Biol Chem 278: 34245–34252.
261. Xiao Z, Latek R, Lodish HF. 2003b. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Oncogene 22: 1057–1069.
262. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, et al. 2009. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200: 916–925.
263. Xu L, Massagué J. 2004. Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 5: 209–219.
264. Xu L, Chen YG, Massagué J. 2000. The nuclear import function of Smad2 is masked by SARA and unmasked by TGF-β-dependent phosphorylation. Nat Cell Biol 2: 559–562.
265. Xu L, Kang Y, Col S, Massagué J. 2002. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGF-β signaling complexes in the cytoplasm and nucleus. Mol Cell 10: 271–282.
266. Xu L, Alarcon C, Col S, Massagué J. 2003. Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J Biol Chem 278: 42569–42577.
267. Xu L, Yao X, Chen X, Lu P, Zhang B, Ip YT. 2007. Msk is required for nuclear import of TGF-β/BMP-activated Smads. J Cell Biol 178: 981–994.
268. Xu P, Liu J, Derynck R. 2012. Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett 586: 1871–1884.
269. Yamaguchi T, Kurisaki A, Yamakawa N, Minakuchi K, Sugino H. 2006. FKBP12 functions as an adaptor of the Smad7–Smurf1 complex on activin type I receptor. J Mol Endocrinol 36: 569–579.
270. Yamakawa N, Tsuchida K, Sugino H. 2002. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBO J 21: 1684–1694.
271. Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. 1994. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269: 20172–20178.
272. Yamashita M, Fatyol K, Jin CY, Wang XC, Liu ZG, Zhang YE. 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell 31: 918–924.
273. Yan X, Chen YG. 2011. Smad7: Not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J 434: 1–10.
274. Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG. 2009. Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling. J Biol Chem 284: 30097–30104.
275. Yan X, Zhang J, Pan L, Wang P, Xue H, Zhang L, Gao X, Zhao X, Ning Y, Chen YG. 2011. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. Mol Cell Biol 31: 3700–3709.
276. Yan G, Zhang L, Fang T, Zhang Q, Wu S, Jiang Y, Sun H, Hu Y. 2012. MicroRNA-145 suppresses mouse granulosa cell proliferation by targeting activin receptor IB. FEBS Lett 586: 3263–3270.
277. Yang KM, Kim W, Bae E, Gim J, Weist BM, Jung Y, Hyun JS, Hernandez JB, Leem SH, Park T, et al. 2012. DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor. Cell Rep 2: 1286–1299.
278. Yang H, Fang F, Chang R, Yang L. 2013. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 58: 205–217.
279. Yao D, Dore JJ Jr, Leof EB. 2000. FKBP12 is a negative regulator of transforming growth factor-β receptor internalization. J Biol Chem 275: 13149–13154.
280. Yao G, Yin M, Lian J, Tian H, Liu L, Li X, Sun F. 2010. MicroRNA-224 is involved in transforming growth fac-tor-β-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 24: 540–551.
281. Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK. 2010. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein–Barr virus reactivation. J Virol 84: 6318–6327.
282. Yu L, Hebert MC, Zhang YE. 2002. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 21: 3749–3759.
283. Yu J, Pan L, Qin X, Chen H, Xu Y, Chen Y, Tang H. 2010. MTMR4 attenuates transforming growth factor β (TGF-β) signaling by dephosphorylating R-Smads in endosomes. J Biol Chem 285: 8454–8462.
284. Yu J, He X, Chen YG, Hao Y, Yang S, Wang L, Pan L, Tang H. 2013. Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. J Biol Chem 288: 79–88.
285. Yukita A, Hosoya A, Ito Y, Katagiri T, Asashima M, Nakamura H. 2012. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells. Bone 50: 1092–1099.
286. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2002. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci 99: 8048–8053.
287. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. 2001. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci 98: 974–979.
288. Zhang L, Zhou H, Su Y, Sun Z, Zhang H, Zhang Y, Ning Y, Chen YG, Meng A. 2004. Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. Science 306: 114–117.
289. Zhang W, Jiang Y, Wang Q, Ma X, Xiao Z, Zuo W, Fang X, Chen YG. 2009. Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization. Proc Natl Acad Sci 106: 15679–15683.
290. Zhang W, Yuan J, Yang Y, Xu L, Wang Q, Zuo W, Fang X, Chen YG. 2010. Monomeric type I and type III transforming growth factor-β receptors and their dimerization revealed by single-molecule imaging. Cell Res 20: 1216–1223.
291. Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, et al. 2012. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol 14: 717–726.
292. Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al. 2013a. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol Cell 51: 559–572.
293. Zhang Q, Sun H, Jiang Y, Ding L, Wu S, Fang T, Yan G, Hu Y. 2013b. MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA. PLoS ONE 8: e59667.
294. Zhang J, Ma W, Tian S, Fan Z, Ma X, Yang X, Zhao Q, Tan K, Chen H, Chen D, et al. 2014. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI. Cell Signal 26: 162–172.
295. Zhao B, Wang Q, Du J, Luo S, Xia J, Chen YG. 2012. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor. Cell Res 22: 1467–1478.
296. Zhao Y, Xiao M, Sun B, Zhang Z, Shen T, Duan X, Yu PB, Feng XH, Lin X. 2014. C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation. J Biol Chem 289: 26441–26450.
297. Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. 2011. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22: 1668–1681.
298. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. 1999. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400: 687– 693.
299. Zhu L, Wang L, Luo X, Zhang Y, Ding Q, Jiang X, Wang X, Pan Y, Chen Y. 2012. Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway. J Biol Chem 287: 39653– 39663.
300. Zumbrennen-Bullough KB, Wu Q, Core AB, Canali S, Chen W, Theurl I, Meynard D, Babitt JL. 2014. MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription. J Biol Chem 289: 23796–23808.
301. Zuo W, Chen YG. 2009. Specific activation of mitogen-activated protein kinase by transforming growth factor-β receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell 20: 1020–1029.
302. Zuo W, Huang F, Chiang YJ, Li M, Du J, Ding Y, Zhang T, Lee HW, Jeong LS, Chen Y, et al. 2013. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Mol Cell 49: 499–510.